WhisperSom Corporation

WhisperSom was founded in 2014 as a Public Benefit Corporation with a goal of at least doubling the 5% sleep apnea treatment rate within five years of FDA authorization of its first treatment device.

WhisperSom is a medical device and informatics company that is partnering with employers to at least double the 5% sleep apnea treatment rate within five years. Studies show that an employee with unmanaged sleep apnea can cost an employer up to $7,000 per year in extra health care, lost productivity, and workplace accidents. Assuming 7% of the workforce has sleep apnea and 5% are treated, the cost approaches $11.7 million per year, or $31,000 per day with 25,000 employees.  Assuming an employer pays for home sleep tests and treatment devices such as CPAP, costing $1,500, the ROI to the employer is 363% Year 1, with 78 days to breakeven, and a 1,754% ROI over a 4-Year device life, assuming adherance with treatment.